[{"AccountsPayableCurrent_0_Q1_USD":11337000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":229652000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":652000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":102400000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2569000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":460000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":32234000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":652000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-72155000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":62000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1231726000.0,"RepaymentsOfRelatedPartyDebt_1_Q1_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":771000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":188385000.0,"NonoperatingIncomeExpense_1_Q1_USD":2455000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":152000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":2455000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":3153000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":203120000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6994000.0,"MarketableSecurities_0_Q1_USD":461848000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":203527000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":352000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":20630000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":15595000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1501000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":652000.0,"IncreaseDecreaseOfRestrictedInvestments_1_Q1_USD":614000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-6800000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":438000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":109332000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":461848000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_1_Q1_USD":115000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_1_Q1_USD":878000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":461085000.0,"AssetsFairValueDisclosure_0_Q1_USD":610907000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6994000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":1532000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5331000.0,"RestrictedInvestmentsNoncurrent_0_Q1_USD":2125000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2569000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":23936000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-80370000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1690000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":191392000.0,"LiabilitiesCurrent_0_Q1_USD":45072000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":732927000.0,"Liabilities_0_Q1_USD":60667000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1853000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-8511000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.36,"CommonStockValue_0_Q1_USD":557000.0,"CommonStockSharesOutstanding_0_Q1_shares":55681027.0,"CommonStockSharesIssued_0_Q1_shares":55681027.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":229652000.0,"AssetsCurrent_0_Q1_USD":703479000.0,"Assets_0_Q1_USD":732927000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7680437.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":763000.0,"NetIncomeLoss_1_Q1_USD":-72807000.0,"ShareBasedCompensation_1_Q1_USD":6994000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":669000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":189175000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":51388000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"OperatingIncomeLoss_1_Q1_USD":-75262000.0,"OperatingExpenses_1_Q1_USD":75324000.0,"InterestPaidNet_1_Q1_USD":0.0,"InterestExpense_1_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":53567434.0,"StockholdersEquity_0_Q1_USD":672260000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-560786000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":6693000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":11979000.0,"SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0_Q1_USD":4600000.0,"Ticker":"DCPH","CIK":"1654151","name":"DECIPHERA PHARMACEUTICALS, INC.","OfficialName":"Deciphera Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"586694767.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]